Cargando…

Informed consent to participation in interventional studies: second-order in a different sense

Detalles Bibliográficos
Autor principal:	Eyal, Nir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2015
Materias:	Peer Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5033560/ https://www.ncbi.nlm.nih.gov/pubmed/27774189 http://dx.doi.org/10.1093/jlb/lsv001

Ejemplares similares

Commentary: Is there a problem Consent in Escrow can solve?
por: Taylor, Holly A.
Publicado: (2015)

Early analysis of deemed consent: why Moorlock’s critique is mistaken
por: Parsons, Jordan A
Publicado: (2021)

Premature presumptions about presumed consent: why Parsons’ comparison is mistaken
por: Moorlock, Greg
Publicado: (2021)

The most plausible pro-coercion view: requiring informed agreement while penalizing non-participation in research
por: Barnhill, Anne
Publicado: (2015)

Consent in escrow: opting to opt in
por: Van der Loos, Kiah I., et al.
Publicado: (2015)

A problem not yet manifest: gaps in insurance coverage of medical interventions after genetic testing
por: Malanga, Sarah, et al.
Publicado: (2015)

Environmental neuroethics: changing the environment—changing the brain Recommendations submitted to the Presidential Commission for the Study of Bioethical Issues
por: Illes, Judy, et al.
Publicado: (2014)

Ethical considerations of neuroscience research and the application of neuroscience research findings for the Presidential Commission for the Study of Bioethical Issues
Publicado: (2014)

Precision medicine: a matter of regulation or collaboration?
por: Knoppers, Bartha Maria
Publicado: (2016)

Neuroscience cannot answer these questions: a response to G. and R. Murrow's essay hypothesizing a link between dehumanization, human rights abuses and public policy
por: Hoffman, Morris B.
Publicado: (2015)

Assessing health-state utility: is there a uniquely privileged perspective?
por: Wasserman, David
Publicado: (2020)

The patent law Duchy of Grand Fenwick: a comment on The mouse that trolled: the long and tortuous history of a gene mutation patent that became an expensive impediment to Alzheimer's research
por: Sarnoff, Joshua D.
Publicado: (2015)

Uterus transplantation: does procreative liberty encompass a right to gestate?
por: Alghrani, Amel
Publicado: (2016)

Peer commentary: in vitro gametogenesis: just another way to have a baby
por: Carbone, June
Publicado: (2016)

‘No, actually your life is going considerably worse’: a comment on Nir Eyal
por: Enoch, David
Publicado: (2020)

Regulating drug promotion to promote the public health: a response to Bennett et al.
por: Zettler, Patricia J.
Publicado: (2015)

We should not vaccinate the young to protect the old: a response to Giubilini, Savulescu, and Wilkinson
por: de Miguel Beriain, Iñigo
Publicado: (2021)

Reporting, recording, and communication of COVID-19 cases in workplace: data protection as a moving target
por: Shabani, Mahsa, et al.
Publicado: (2020)

Informed consent: time for more transparency
por: Yazici, Yusuf, et al.
Publicado: (2010)

Science wars—How much risk should soldiers be exposed to in military experimentation?
por: Savulescu, Julian
Publicado: (2015)

Dehumanization: its operations and its origins
por: Simpson, Robert Mark
Publicado: (2015)

Hate speech, volition, and neurology
por: Roginsky, Alexandra B., et al.
Publicado: (2015)

Egg freezing, stratified reproduction and the logic of not
por: Ikemoto, Lisa C.
Publicado: (2015)

‘Good soldiers are made, not born’(⊥): the dangers of medicalizing ability in the military use of genetics
por: Roberts, Jessica L.
Publicado: (2015)

Two kinds of rule regulating human subjects research
por: Sachs, Benjamin
Publicado: (2015)

Are ethics promulgations self-defeating?
por: Gray, Derrick
Publicado: (2015)

Diversion effects, incentive effects, and the goals of research ethics promulgations
por: Wenner, Danielle M.
Publicado: (2015)

The problems of liminal states, line drawing, and false dichotomies
por: Suter, Sonia
Publicado: (2015)

Off-label drug promotion and the ephemeral line between marketing and education
por: Krause, Joan H.
Publicado: (2015)

The mouse that trolled
por: Hardy, John
Publicado: (2015)

FDA's pathway for regulation of FMT: not so fraught
por: Riley, Margaret F., et al.
Publicado: (2015)

Universities and Patent Demands
por: Cordova, Andrew K., et al.
Publicado: (2015)

It depends whose data are being shared: considerations for genomic data sharing policies
por: Robinson, Jill O., et al.
Publicado: (2015)

Orphan drug incentives in the pharmacogenomic context: policy responses in the USA and Canada
por: Herder, Matthew
Publicado: (2016)

Buttressing regulation of cognitive enhancement devices with principles of harm reduction
por: Fitz, Nicholas S., et al.
Publicado: (2014)

Regulation of cognitive enhancement devices: commentary
por: Johnson, Reuben, et al.
Publicado: (2014)

Medical regulation of cognitive enhancement devices: some concerns
por: King, Mike, et al.
Publicado: (2014)

The brain, cognitive enhancement devices, and European regulation
por: Kuersten, Andreas, et al.
Publicado: (2014)

Outstanding questions concerning the regulation of cognitive enhancement devices
por: De Ridder, Dirk, et al.
Publicado: (2014)

Law and neuroscience: recommendations submitted to the President's Bioethics Commission
por: Jones, Owen D., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_igc28qg12cj5id8mud9mlnf78h